NASDAQ: SNCE - Science 37 Holdings, Inc.

Rentabilidade por seis meses: 0%
Rendimento de dividendos: 0.00%
Setor: Healthcare

Cronograma de promoção Science 37 Holdings, Inc.

Agenda avançada Gráfico simples
Financial Markets by TradingView

Sobre a empresa Science 37 Holdings, Inc.

Science 37 Holdings, Inc. engages in patient-centric clinical trial activities in North Carolina. Its platform enables modern and digital approaches to clinical research, including the patient and trial investigators, nurses, coordinators, and sponsors, standardize evidence generation, and harmonize data.

mais detalhes
The company's platform also provides specialized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators, and connected devices for orchestrating clinical trials; and extensive configuration to support virtually any phase of clinical study and therapeutic area. In addition, the company licenses its proprietary hosted technology platform to various life science institutions. It serves large and mid-sized pharmaceutical companies, contract research organizations, academic institutions, and biotech companies. Science 37 Holdings, Inc. was founded in 2014 and is based in Research Triangle Park, North Carolina.
Adicionar à lista de comparação
Adicionar à lista de observação
Adicionar ao portfólio
Adicionar aviso de preço

IPO date 2020-11-20
ISIN US8086441081
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.science37.com
Цена ао 5.75
Alteração de preço por dia: 0% (5.75)
Alteração de preço por semana: 0% (5.75)
Alteração de preço por mês: 0% (5.75)
Alteração de preço em 3 meses: 0% (5.75)
Mudança de preço em seis meses: 0% (5.75)
Mudança de preço por ano: +0.1742% (5.74)
Mudança de preço em 3 anos: -26.56% (7.83)
Mudança de preço em 5 anos: 0% (5.75)
Mudança de preço em 10 anos: 0% (5.75)
Mudança de preço desde o início do ano: 0% (5.75)
Todos os parâmetros

Subestimação

Nome Significado Nota
P/S 0.6789 10
P/BV 0.489 10
P/E 0 0
EV/EBITDA 0.4243 10
Total: 6.25

Eficiência

Nome Significado Nota
ROA, % -26.33 0
ROE, % -46.57 0
Total: 0

Dividendos

Nome Significado Nota
Div yield, % 0 0
DSI 0 0
Total: 0

Obrigação

Nome Significado Nota
Debt/EBITDA -0.0093 10
Total: 9.8

Impulso de crescimento

Nome Significado Nota
Rentabilidade Revenue, % 154.27 10
Rentabilidade Ebitda, % 426.07 10
Rentabilidade EPS, % 11478.95 10
Total: 10
Mais detalhes

Instituições Volume Compartilhar, %
Redmile Group, LLC 990412 0.83
Kent Lake Capital, LLC 278560 0.23
Glynn Capital Management Llc 176992 0.15
Russell Investments Group, Ltd. 169696 0.14
Vanguard Group Inc 160367 0.13
Alphabet Inc. 160364 0.13
MIC Capital Management UK LLP 117295 0.1
Alyeska Investment Group, L.P. 88319 0.07
Citadel Advisors Llc 67631 0.06
Samsara BioCapital, LLC 45000 0.04



Supervisor Cargo Pagamento Ano de nascimento
Mr. David Coman CEO & Director 796.13k 1970 (55 anos)
Ms. Christine A. Pellizzari J.D. Chief Legal & Human Resources Officer and Secretary 521.58k 1968 (57 anos)
Ms. Darcy Forman Chief Delivery Officer 550.58k 1976 (49 anos)
Mr. Mike Zaranek Chief Financial Officer N/A 1971 (54 ano)
Irena Lambridis VP and Head of Quality Assurance & Compliance N/A
Ms. Margie Gimbel Kooman Vice President of Marketing & Communications N/A
Mr. Drew Bustos Chief Strategy & Marketing Officer N/A
Mr. Jonathan Cotliar M.D. Chief Medical Officer 486.6k 1972 (53 ano)
Mr. Michael Shipton Chief Commercial Officer N/A 1972 (53 ano)
Mr. Tyler Van Horn VP of Corporate Strategy & Chief of Staff N/A

Endereço: United States, Research Triangle Park. NC, 800 Park Offices Drive - abrir no Google Maps, abrir mapas Yandex
Site: https://www.science37.com